Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07765511
What this trial is testing

Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 60
Not applicableActive Not RecruitingNCT05227105
What this trial is testing

PA Moves Trial - Patient Participants

Who this might be right for
Overweight or ObesityDiabetes Mellitus, Type 2Physical Inactivity
University of Pittsburgh 640
Not applicableStudy completedNCT01464073
What this trial is testing

Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat

Who this might be right for
Obesity
Centre Hospitalier Universitaire de la Réunion 137
Early research (Phase 1)Looking for participantsNCT07803809
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06858878
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Amgen 1,105
Early research (Phase 1)Study completedNCT06615700
What this trial is testing

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType 2 Diabetes
Biomed Industries, Inc. 74
Not applicableStudy completedNCT05144737
What this trial is testing

A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2PreDiabetes+7 more
Johns Hopkins University 60
Testing effectiveness (Phase 2)Ended earlyNCT07030868
What this trial is testing

LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweightType 2 Diabetes
Eli Lilly and Company 1
Post-approval studies (Phase 4)Study completedNCT02019264
What this trial is testing

Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Who this might be right for
Cardiovascular DiseaseHigh Cardiovascular RiskObesity+2 more
Eisai Inc. 14,673
Not applicableNot Yet RecruitingNCT05857319
What this trial is testing

Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

Who this might be right for
Overweight and ObesityCardiovascular DiseasesMetabolic Disease+4 more
Groupe Éthique et Santé 10,000
Large-scale testing (Phase 3)Study completedNCT05803421
What this trial is testing

Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Who this might be right for
Type 2 DiabetesObesityOverweight or Obesity+3 more
Eli Lilly and Company 2,749
Not applicableLooking for participantsNCT07728669
What this trial is testing

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)Overweight+1 more
Kazakh Academy of Nutrition 120
Early research (Phase 1)Ended earlyNCT01614782
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 24
Not applicableActive Not RecruitingNCT06073457
What this trial is testing

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

Who this might be right for
ObesityType 2 Diabetes
GT Metabolic Solutions, Inc. 35
Not applicableStudy completedNCT05456347
What this trial is testing

Effect of a Low-calorie and High-protein Diet Specially Rich in Animal Protein Compared to a Low-calorie and High-protein Diet Specially Rich in Plant Protein on Glucose Metabolism in Subjects With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Who this might be right for
Diabetes Mellitus, Type 2Overweight and ObesityPreDiabetes
Universidad de Zaragoza 120
Testing effectiveness (Phase 2)Study completedNCT02871882
What this trial is testing

Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusObeseOverweight
Mayo Clinic 24
Large-scale testing (Phase 3)Study completedNCT03552757
What this trial is testing

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Who this might be right for
ObesityOverweight
Novo Nordisk A/S 1,210
Large-scale testing (Phase 3)Study completedNCT01208558
What this trial is testing

Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss

Who this might be right for
Abdominal ObesityCardiovascular DiseasesDiabetes Type 2+2 more
Lund University 105
Not applicableStudy completedNCT06660134
What this trial is testing

Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atrial Fibrillation (AF)
Shanghai Chest Hospital 174
Large-scale testing (Phase 3)Study completedNCT02868177
What this trial is testing

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

Who this might be right for
PrediabetesType 2 DiabetesHypertriglyceridemia+3 more
Valbiotis 66
Next Page